Overview

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

Status:
Completed

Trial end date:
2004-04-01

Target enrollment:

Participant gender:

Summary

The study was performed to see if a single, 2.0-g oral dose of azithromycin sustained release (SR) was at least as effective as a 7-day regimen of levofloxacin (500 mg once daily) for the treatment of mild to moderate community-acquired pneumonia, and to assess the efficacy and safety of both treatment regimens.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Azithromycin
Levofloxacin
Ofloxacin